Firazyr and Quincke's disease - a phase IV clinical study of FDA data
Quincke's disease is found among people who take Firazyr, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Firazyr and have Quincke's disease. It is created by eHealthMe based on reports of 4,444 people who have side effects when taking Firazyr from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,444 people reported to have side effects when taking Firazyr.
Among them, 1,985 people (44.67%) have Quincke's disease.
What is Firazyr?
Firazyr has active ingredients of icatibant acetate. eHealthMe is studying from 4,446 Firazyr users for its effectiveness, alternative drugs and more.
What is Quincke's disease?
Quincke's disease (a form of localized swelling of the deeper layers of the skin and fatty tissues beneath the skin) is found to be associated with 976 drugs and 481 conditions by eHealthMe.
Number of Firazyr and Quincke's disease reports submitted per year:
Time on Firazyr when people have Quincke's disease *:
Gender of people who have Quincke's disease when taking Firazyr*:
Age of people who have Quincke's disease when taking Firazyr *:
Common drugs people take besides Firazyr *:
Common side effects people have besides Quincke's disease *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Firazyr and have Quincke's disease?Check whether Quincke's disease is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Quincke's disease and when was it recovered:
Expand to all the drugs that have ingredients of icatibant acetate:
Alternative drugs to, pros and cons of Firazyr:
- Firazyr (4,446 reports)
Common Firazyr side effects:
- Hereditary angioedema (recurrent episodes of severe swelling): 1,985 reports
- Drug ineffective: 349 reports
- Headache (pain in head): 158 reports
- Fatigue (feeling of tiredness): 118 reports
Browse all side effects of Firazyr:a b c d e f g h i j k l m n o p q r s t u v w x y z
Quincke's disease treatments and more:
- Quincke's disease (16,202 reports)
COVID vaccines that are related to Quincke's disease:
- Quincke's disease in Moderna COVID Vaccine
- Quincke's disease in Pfizer BioNTech Covid Vaccine
- Quincke's disease in Johnson and Johnson Covid Vaccine
Common drugs associated with Quincke's disease:
- Firazyr: 1,985 reports
- Kalbitor: 787 reports
- Heparin: 440 reports
- Hydramine: 413 reports
- Diphen: 413 reports
- Epipen: 379 reports
- Zofran: 293 reports
- Zyrtec: 273 reports
- Benadryl: 260 reports
- Vitamin d: 217 reports
All the drugs that are associated with Quincke's disease:
- Quincke's disease (976 drugs)
Common conditions associated with Quincke's disease:
- Hereditary angioedema: 1,067 reports
- Preventive health care: 680 reports
All the conditions that are associated with Quincke's disease:
- Quincke's disease (481 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on icatibant acetate (the active ingredients of Firazyr) and Firazyr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Spironolactone and Suicidal Ideation - now
- Levoxyl and Beclovent drug interaction - a second ago
- Jardiance and Depression Aggravated - 2 seconds ago
- Lisinopril and Emgality drug interaction - 3 seconds ago
- Tenormin and Self-Injurious Ideation - 5 seconds ago
- Dexchlorpheniramine Maleate and Bradycardia - 7 seconds ago
- Westcort and Lisinopril drug interaction - 9 seconds ago
- Lorcet-Hd and Peridex drug interaction - 15 seconds ago
- Viorele vs. Loryna - 16 seconds ago
- Colchicine and Remicade drug interaction - 16 seconds ago